CHCHD3 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor affecting the PI3K/Akt/mTOR pathway. Rapamycin indirectly influences CHCHD3 by modulating mitochondrial function through mTORC1 inhibition. This alteration in mitochondrial dynamics can impact CHCHD3 indirectly, potentially affecting its cellular functions and interactions within the mitochondrial environment. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $175.00 $600.00 $1179.00 $5100.00 $9180.00 | 26 | |
ATP synthase inhibitor affecting oxidative phosphorylation. Oligomycin A indirectly influences CHCHD3 by disrupting ATP production and mitochondrial function. This metabolic stress can lead to alterations in CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $92.00 $348.00 | 46 | |
Uncoupling agent impacting mitochondrial membrane potential. FCCP indirectly influences CHCHD3 by disrupting mitochondrial integrity and function. This disruption in mitochondrial homeostasis can modulate CHCHD3-dependent processes, offering a potential avenue for indirect inhibition of CHCHD3. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Complex I inhibitor impacting mitochondrial electron transport. Rotenone indirectly influences CHCHD3 by disrupting the electron transport chain, leading to alterations in mitochondrial function. These changes can impact CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $54.00 $62.00 $1642.00 $4600.00 | 51 | |
Complex III inhibitor affecting mitochondrial electron transport. Antimycin A indirectly influences CHCHD3 by disrupting the electron transport chain, leading to alterations in mitochondrial function. These changes can impact CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $75.00 $150.00 $235.00 | 8 | |
Uncoupling agent impacting mitochondrial membrane potential. CCCP indirectly influences CHCHD3 by disrupting mitochondrial integrity and function. This disruption in mitochondrial homeostasis can modulate CHCHD3-dependent processes, offering a potential avenue for indirect inhibition of CHCHD3. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
AMPK activator affecting cellular energy sensing. A769662 indirectly influences CHCHD3 by modulating AMPK activity and downstream pathways associated with energy metabolism. This metabolic modulation can impact CHCHD3-dependent processes, providing a potential avenue for indirect inhibition of CHCHD3. | ||||||
UK 5099 | 56396-35-1 | sc-361394 sc-361394A | 10 mg 50 mg | $154.00 $633.00 | 5 | |
Inhibitor of mitochondrial pyruvate carrier. UK5099 indirectly influences CHCHD3 by disrupting mitochondrial pyruvate transport and altering cellular metabolism. These metabolic changes can impact CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $66.00 $124.00 $246.00 $456.00 | 13 | |
Dynamin-related protein 1 (Drp1) inhibitor affecting mitochondrial fission. Mdivi-1 indirectly influences CHCHD3 by modulating mitochondrial dynamics and morphology. This alteration in mitochondrial structure can impact CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||
Atractyloside A | 126054-77-1 | sc-503160 | 5 mg | $380.00 | ||
ADP/ATP translocase inhibitor impacting mitochondrial energy metabolism. Atractyloside indirectly influences CHCHD3 by disrupting mitochondrial nucleotide exchange and altering cellular energetics. These metabolic changes can impact CHCHD3-dependent processes, providing a potential avenue for modulating its cellular functions. | ||||||